QUEST DIAGNOSTICS INC
StreetZero Signal 66
About QUEST DIAGNOSTICS INC
Quest Diagnostics (NYSE: DGX) offers medical diagnostic testing and services in areas such as allergy and asthma, cancer, chronic disease, and digestive health. The company was founded in 1967 and is headquartered in Secaucus, New Jersey. It operates as a public company in the Medical and Diagnostic Laboratories industry with annual revenue of 11.03B USD.
LATEST FUNDINGRule 144
$5.6M
Announced 2026-11-03
TOTAL RAISED3.10B USD
IN THE NEWS
- 🔗 QUEST DIAGNOSTICS INC
- 🔗 Quest Diagnostics Portfolio Investments, Quest Diagnostics Funds, Quest Diagnostics Exits
- 🔗 Quest Diagnostics - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- 🔗 DGX SEC Filings, May 8-21, 2026 - QUEST DIAGNOSTICS INC Filing Archive
- 🔗 Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
EMPLOYEES48000
FOUNDED1967
HQSecaucus, NJ, United States
Industry
Public Equity (NYSE)
Tags
HealthcareDiagnosticsPublic Company
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Public company (NYSE: DGX) founded in 1967 with headquarters in Secaucus, NJ.
- Operates medical diagnostic testing services across multiple health categories.
- Completed $5.58M Rule 144 placement with investors not disclosed.
- Maintains 48,000 employees and reports 11.03B USD annual revenue.
Ask StreetZero about QUEST DIAGNOSTICS INC
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account